Email to Cochrane Governing Board: 24 June 2023

Further to my previous post about the complaint about Cochrane’s Editor in Chief, I wrote to the Cochrane support address given if you want to contact Cochrane’s Governing Board. 24 June 2023 Dear Cochrane Support (cc Gillian Leng, Lorraine Ross, Charity Commission) I have asked at least once for you to forward correspondence regarding complaints… Continue reading Email to Cochrane Governing Board: 24 June 2023

Preparing a complaint to Cochrane: January 2023

I am preparing to send a complaint about Cochrane Editor-in-Chief Karla Soares-Weiser for allowing Cochrane authors to ignore an explicit instruction from arbitrator Gordon Guyatt to highlight in the amended Exercise Therapy for Chronic Fatigue Syndrome that exercise has no important effect on fatigue. I have written to Cochrane CEO Catherine Spencer for more detail… Continue reading Preparing a complaint to Cochrane: January 2023

Letter to Cochrane with a suggestion about the update to the Exercise therapy for ME/CFS review: 19 March 2022

Yesterday I wrote to Rachel Marshall, the Cochrane Senior Editor who is managing the project to update Cochrane’s review of Exercise Therapy for ME/CFS. There have been no updates on the progress of the review since July last year, despite a commitment from Cochrane to keep patient groups regularly informed of progress.” I copied in… Continue reading Letter to Cochrane with a suggestion about the update to the Exercise therapy for ME/CFS review: 19 March 2022

Letter to Gill Leng, outgoing CEO, NICE, 31 December 2021

On 26 November 2021 I wrote to Toby Lasserson, Cochrane’s Deputy Editor-in-Chief, copying in in Gill Leng the Chief Executive Officer of NICE. I received a short response from Cochrane on 9 December. Today, 31 December, I wrote to Gill Leng, outgoing CEO of NICE copying in the incoming CEO of NICE, and other relevant… Continue reading Letter to Gill Leng, outgoing CEO, NICE, 31 December 2021

Correspondence with Cochrane about the Exercise for CFS review July 2019-February 2020

This correspondence started after a meeting with new Editor-in-Chief Karla Soares-Weiser on Tuesday 16 July 2019. Karla has not responded in a substantive way to any of my emails. My main concern after the amended review was published in October, that there was no indication on the review itself that an update was planned. I… Continue reading Correspondence with Cochrane about the Exercise for CFS review July 2019-February 2020